Loading clinical trials...
Loading clinical trials...
This observational study is to develop and validate the prediction model for functional mitral regurgitation regression in heart failure patients taking GDMT. The patients diagnosed ≥2+ functional mitral regurgitation by ultrasonic cardiogram are enrolled in this study and would be clinically followed by at least one year (clinical visit at 3 months, 6 months, and 12 months), and then by when the endpoints are reached.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Sun-Yatsen Memorial Hospital
Guangzhou, Guangdong, China
Start Date
January 1, 2024
Primary Completion Date
June 1, 2025
Completion Date
December 31, 2025
Last Updated
February 26, 2024
270
ESTIMATED participants
angiotensin-converting enzyme inhibitors/angiotensin II receptor blocker/angiotensin receptor-neprilysin inhibitor
DRUG
The development of the prediction model
OTHER
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
NCT07191730
NCT07484009
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions